This work demonstrates improved glutathione detection using gold nanoclusters, indicating potential advancements in point-of-care testing for oxidative stress disorders.
Glutathione (GSH), a pivotal regulator of cellular redox homeostasis, requires precise monitoring for clinical diagnostics. This work develops bovine serum albumin‐templated gold nanoclusters (BSA‐AuNCs) through in situ chloroauric acid reduction, exhibiting orange fluorescence ( λ em = 610 nm) with 35.8% quantum yield. Systematic evaluation of pH‐dependent and time‐resolved quenching behavior revealed optimal GSH detection at physiological pH 7.4 within 3 min. The nanozyme demonstrated linear responsivity from 10 nM to 3 μM (Limit of Detection, LOD = 8.7 nM) and validated applicability in biological matrices (urine/serum) with 98.0%–103.3% recovery rates. This photoluminescent platform enables reliable GSH biomarker quantification, advancing point‐of‐care testing for oxidative stress disorders.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: